Clinical trials
Recruiting Phase 1 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
178 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 14 |
| 2022 | 15 |
| 2023 | 16 |
| 2024 | 40 |
| 2025 | 56 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 178 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Eli Lilly and Company | 5 |
| AstraZeneca | 4 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 4 |
| Bristol-Myers Squibb | 3 |
| City of Hope Medical Center | 3 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 3 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 3 |
| AbbVie | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 178 |
| Colorectal Neoplasms | 49 |
| Lung Neoplasms | 37 |
| Squamous Cell Carcinoma of Head and Neck | 30 |
| Triple Negative Breast Neoplasms | 29 |
| Neoplasm Metastasis | 28 |
| Breast Neoplasms | 25 |
| Stomach Neoplasms | 22 |
| Ovarian Neoplasms | 20 |
| Endometrial Neoplasms | 19 |
Trials
Showing 1 to 25 of 178. Each trial links to its page on Pharma Observatory.
78 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.